These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32884883)

  • 1. Rigid Scaffolds: Synthesis of 2,6-Bridged Piperazines with Functional Groups in all three Bridges.
    Gao D; Penno C; Wünsch B
    ChemistryOpen; 2020 Aug; 9(8):874-889. PubMed ID: 32884883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly stereoselective, one-pot synthesis of azetidines and 2,4-dioxo-1,3-diazabicyclo[3.2.0] compounds mediated by I2.
    Miao CB; Dong CP; Zhang M; Ren WL; Meng Q; Sun XQ; Yang HT
    J Org Chem; 2013 May; 78(9):4329-40. PubMed ID: 23573992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of bicyclic sigma receptor ligands with cytotoxic activity.
    Geiger C; Zelenka C; Weigl M; Fröhlich R; Wibbeling B; Lehmkuhl K; Schepmann D; Grünert R; Bednarski PJ; Wünsch B
    J Med Chem; 2007 Nov; 50(24):6144-53. PubMed ID: 17967001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective synthesis of conformationally restricted KOR agonists based on the 2,5-diazabicyclo[2.2.2]octane scaffold.
    Wittig C; Schepmann D; Soeberdt M; Daniliuc CG; Wünsch B
    Org Biomol Chem; 2017 Aug; 15(31):6520-6540. PubMed ID: 28745376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between the structure of 6-allyl-6,8-diazabicyclo[3.2.2]nonane derivatives and their sigma receptor affinity and cytotoxic activity.
    Holl R; Schepmann D; Grünert R; Bednarski PJ; Wünsch B
    Bioorg Med Chem; 2009 Jan; 17(2):777-93. PubMed ID: 19081725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of conformationally restricted σ(1) receptor ligands with 7,9-diazabicyclo[4.2.2]decane scaffold.
    Sunnam SK; Schepmann D; Rack E; Fröhlich R; Korpis K; Bednarski PJ; Wünsch B
    Org Biomol Chem; 2010 Dec; 8(24):5525-40. PubMed ID: 20953473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 7-azabicyclo[2.2.1]heptane and 2-oxa-4-azabicyclo[3.3.1]non-3-ene derivatives by base-promoted heterocyclization of alkyl N-(cis(trans)-3,trans(cis)-4-dibromocyclohex-1-yl)carbamates and N-(cis(trans)-3,trans(cis)-4-dibromocyclohex-1-yl)-2,2,2-trifluoroacetamides.
    Gómez-Sanchez E; Soriano E; Marco-Contelles J
    J Org Chem; 2007 Nov; 72(23):8656-70. PubMed ID: 17927252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of bridged piperazines with sigma receptor affinity.
    Weigl M; Wünsch B
    Eur J Med Chem; 2007 Oct; 42(10):1247-62. PubMed ID: 17420073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thietanyl Protection in the Synthesis of 8-Substituted 1-Benzyl-3-methyl-3,7-dihydro- 1H-purine-2,6-diones.
    Khaliullin F; Shabalina Y
    Curr Org Synth; 2020; 17(7):535-539. PubMed ID: 32600234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total Synthesis of (±)-Eucophylline. A Free-Radical Approach to the Synthesis of the Azabicyclo[3.3.1]nonane Skeleton.
    Hassan H; Mohammed S; Robert F; Landais Y
    Org Lett; 2015 Sep; 17(18):4518-21. PubMed ID: 26348122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.
    Kim MG; Bodor ET; Wang C; Harden TK; Kohn H
    J Med Chem; 2003 May; 46(11):2216-26. PubMed ID: 12747793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bicyclic analogues of piperazine. X. (1)-N-Aminoderivatives of 3,8-diazabicyclo-(3.2.1)-octane, 3,8-diazabicyclo-3(3.2.1)-octane-2,4-dione and 2,6-dimethylpiperazine with potential pharmacologic activity].
    Fontanella L; Occelli E; Testa E; Cignarella G
    Farmaco Sci; 1972 Sep; 27(9):755-72. PubMed ID: 4666085
    [No Abstract]   [Full Text] [Related]  

  • 13. Conformationally constrained kappa receptor agonists: stereoselective synthesis and pharmacological evaluation of 6,8-diazabicyclo[3.2.2]nonane derivatives.
    Geiger C; Zelenka C; Lehmkuhl K; Schepmann D; Englberger W; Wünsch B
    J Med Chem; 2010 May; 53(10):4212-22. PubMed ID: 20441176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of SNC80 analogues with a bridged piperazine ring.
    Holl R; Jung B; Schepmann D; Humpf HU; Grünert R; Bednarski PJ; Englberger W; Wünsch B
    ChemMedChem; 2009 Dec; 4(12):2111-22. PubMed ID: 19827086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bicyclic piperazine homologues XIV (1). Synthesis and analgesic activity of 3,8-diaza-bicyclo[3.2.1.] octane derivatives].
    Ocelli E; Fontanella L; Diena A
    Farmaco Sci; 1978 Jun; 33(6):401-20. PubMed ID: 738456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semipinacol rearrangement of cis-fused β-lactam diols into keto-bridged bicyclic lactams.
    Grainger RS; Betou M; Male L; Pitak MB; Coles SJ
    Org Lett; 2012 May; 14(9):2234-7. PubMed ID: 22512321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of Novel Functional Molecules Based on the Molecular Structure Characteristics of Diketopiperazines].
    Nakao M
    Yakugaku Zasshi; 2017; 137(12):1505-1516. PubMed ID: 29199259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A general synthesis of bis-indolylpiperazine-2,5-diones.
    Crooke S; Whitlock C
    Molecules; 2012 Dec; 17(12):14841-5. PubMed ID: 23519256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 7,9-diazabicyclo[4.2.2]decanes as conformationally restricted κ receptor agonists: fine tuning of the dihedral angle of the ethylenediamine pharmacophore.
    Sunnam SK; Rack E; Schepmann D; Wünsch B
    Eur J Med Chem; 2011 Jun; 46(6):1972-82. PubMed ID: 21481987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dancing of the second aromatic residue around the 6,8-diazabicyclo[3.2.2]nonane framework: influence on sigma receptor affinity and cytotoxicity.
    Holl R; Schepmann D; Fröhlich R; Grünert R; Bednarski PJ; Wünsch B
    J Med Chem; 2009 Apr; 52(7):2126-37. PubMed ID: 19243173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.